Vertex Pharmaceuticals (VRTX) Receivables (2009 - 2026)
Vertex Pharmaceuticals' Receivables was $2.13 billion in Q2 2026, up 12.7% from $1.89 billion a year earlier and up 6.9% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Vertex Pharmaceuticals came in at $2.05 billion, up 27.6% from FY2024.
- Receivables has now increased for 11 consecutive years, with a five-year compound annual growth rate of 18.3% (FY2020 to FY2025).
- In earlier years, Receivables was $1.61 billion in FY2024 (+2.9%), $1.56 billion in FY2023 (+8.4%), $1.44 billion in FY2022 (+26.9%) and $1.14 billion in FY2021 (+28.4%).
- The Q2 2026 figure marks the highest quarterly Receivables in data going back to Q4 2009.
- Compared with a year earlier, Receivables has increased for 46 straight quarters, with growth averaging 11.7% over the last eight quarters.
- The year-over-year growth in Receivables has ranged between 0.7% (Q1 2025) and 43.5% (Q2 2022) over the last five years.
- Per Business Quant data, VRTX's Receivables in the three quarters before Q2 2026 was $2 billion (Q1 2026), $2.05 billion (Q4 2025) and $1.95 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 10.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Bn |
| Mar 31, 2026 | 2.00 Bn |
| Dec 31, 2025 | 2.05 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.89 Bn |
| Mar 31, 2025 | 1.81 Bn |
| Dec 31, 2024 | 1.61 Bn |
| Sep 30, 2024 | 1.75 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.79 Bn |
| Dec 31, 2023 | 1.56 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.56 Bn |
| Mar 31, 2023 | 1.55 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Sep 30, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.33 Bn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.14 Bn |
| Sep 30, 2021 | 1.10 Bn |
API Access
Vertex Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();